Abzena PLC | Mutual Funds
Mutual Funds that own Abzena PLC
CF Woodford Equity Income
42,791,947
19.98%
0
0.11%
07/31/2018
Invesco Perpetual UK Invt. Ser. - High Income
33,669,252
15.72%
0
0.05%
03/29/2018
Invesco Perpetual UK 2 Invt. Series - Income Fund
21,502,027
10.03%
0
0.07%
03/29/2018
Marlborough UK Micro Cap Growth Fund
13,824,040
6.45%
-601,031
0.18%
03/29/2018
Marlborough Special Situations Fund
6,277,120
2.93%
-272,912
0.06%
03/29/2018
Baillie Gifford UK & Balanced Fund - British Smaller Companies
3,472,768
1.62%
0
0.27%
04/30/2018
1,925,554
0.9%
-875,946
0.03%
06/30/2018
SVM Funds ICVC - UK Opportunities Fund
1,753,833
0.82%
620,500
0.16%
12/31/2017
1,102,089
0.51%
-47,916
0.1%
03/29/2018
SVM Funds ICVC - All Europe SRI Fund
308,167
0.14%
-108,500
0.18%
12/31/2017
| Address |
Babraham Research Campus
Cambridge Cambridgeshire CB22 3AT
United Kingdom
|
|
Employees
|
- |
| Website |
http://abzena.com/ |
| Updated |
09/14/2018 |
| Abzena Plc engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It operates through the following segments: Biology, Chemistry, and Biomanufacturing. Its services include: antibody discovery and candidate screening; immunology and immunogenicity assessment; antibody and protein engineering to reduce immunogenicity; and custom synthesis of cytotoxic payloads, reagents, and other small molecules. |
